Dasatinib

Dasatinib, is an oral Bcr-Abl Tyrosine Kinase inhibitor and Src family Tyrosine Kinase inhibitor approved for first line use in patients with chronic myelogenous leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia.

Dasatinib
 

Impurities available for : Dasatinib

Dasatinib N-Oxide
Dasatinib N-Oxide
CAS Number : 910297-52-8
CAT Number : ANT-DST-01
Molecular Weight : 504.00
Molecular Formula : C₂₂H₂₆ClN₇O₃S